Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:HexCer 18:0;O2/20:0)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004300 AN007152 Two-dimensional liquid chromatography-mass spectrometry (2DLC-MS) platform to conduct an in-depth lipidomic analysis of liver and brain tissues from fat-1 transgenic mice exposed to ethanol. Brain Mouse Liver disease University of Louisville LC-MS
ST004300 AN007152 Two-dimensional liquid chromatography-mass spectrometry (2DLC-MS) platform to conduct an in-depth lipidomic analysis of liver and brain tissues from fat-1 transgenic mice exposed to ethanol. Liver Mouse Liver disease University of Louisville LC-MS
ST004300 AN007154 Two-dimensional liquid chromatography-mass spectrometry (2DLC-MS) platform to conduct an in-depth lipidomic analysis of liver and brain tissues from fat-1 transgenic mice exposed to ethanol. Brain Mouse Liver disease University of Louisville LC-MS
ST004300 AN007154 Two-dimensional liquid chromatography-mass spectrometry (2DLC-MS) platform to conduct an in-depth lipidomic analysis of liver and brain tissues from fat-1 transgenic mice exposed to ethanol. Liver Mouse Liver disease University of Louisville LC-MS
ST004002 AN006600 A deep, quantitative lipid atlas of extracellular vesicles across multiple cell lines Extracellular vescicles Human Cancer European Molecular Biology Laboratory LC-MS
ST004002 AN006600 A deep, quantitative lipid atlas of extracellular vesicles across multiple cell lines Extracellular vescicles Mouse Cancer European Molecular Biology Laboratory LC-MS
ST004002 AN006601 A deep, quantitative lipid atlas of extracellular vesicles across multiple cell lines Extracellular vescicles Human Cancer European Molecular Biology Laboratory LC-MS
ST004002 AN006601 A deep, quantitative lipid atlas of extracellular vesicles across multiple cell lines Extracellular vescicles Mouse Cancer European Molecular Biology Laboratory LC-MS
ST003703 AN006075 NAD Depletion in Skeletal Muscle does not Compromise Muscle Function or Accelerate Aging Muscle Mouse Sarcopenia University of Copenhagen LC-MS
ST003672 AN006030 Advanced Lipidomics Using UHPLC-ESI-QTOF-MS/MS Reveals Novel Lipids in Hibernating Syrian Hamsters Brain Golden hamster Universidad CEU San Pablo LC-MS
ST003661 AN006017 Lipidomics facilitates the discovery of diagnostic biomarkers in patients with chronic total occlusion during the perioperative period Blood Human Cardiovascular disease Zhongshan Hospital Fudan University LC-MS
ST003528 AN005796 Lipidomics profiling of livers from Alb-Cre +/- SART-/- (KO) versus age matched wild type WT mouse littermates to characterize progression to hepatic steatosis and hepatocellular carcinoma Liver Mouse Cancer University of Utah LC-MS
ST003326 AN005448 Lipidome profiling in non-alcoholic steatohepatitis identifies phosphatidylserine synthase 1 as a regulator of hepatic lipoprotein metabolism Liver Mouse Liver disease University of Melbourne LC-MS
ST003220 AN005280 Obesity, sex, and depot drive distinct lipid profiles in murine white adipose tissue Adipose tissue Mouse Obesity University of Utah LC-MS
ST002400 AN003908 Alcohol dehydrogenase 1B is crucial for adipocyte homeostasis Cultured cells Human INSERM LC-MS
ST001888 AN003059 A Metabolome Atlas of the Aging Mouse Brain (Study part II) Brain Mouse University of California, Davis GC-MS/LC-MS
ST001637 AN002677 A Metabolome Atlas of the Aging Mouse Brain Brain Mouse University of California, Davis GC-MS/LC-MS
ST001477 AN002453 Lipidomics dataset of PTEN deletion-induced nerve regeneration mouse model Eye tissue Mouse Eye disease University of Miami LC-MS
ST001288 AN002141 Subcellular organelle lipidomics in TLR-4-activated macrophages Macrophages Mouse LIPID MAPS LC-MS
ST000917 AN001501 Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 3:Urine Urine Human Fatty liver disease LIPID MAPS GC-MS/LC-MS
ST000916 AN001495 Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Plasma Blood Human Fatty liver disease LIPID MAPS GC-MS/LC-MS
ST000915 AN001489 Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Liver Liver Human Fatty liver disease LIPID MAPS GC-MS/LC-MS
ST000004 AN000006 Lipidomics studies on NIDDK / NIST human plasma samples Blood Human LIPID MAPS LC-MS
  logo